Adage Capital Partners
EPIX

Adage Capital Partners’s ESSA Pharma EPIX Stock Holding History

Adage Capital Partners’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,474,165
Closed -$8.93M – 902
2024
Q3 		$8.93M Hold
1,474,165
– – 0.02% 630
2024
Q2 		$7.75M Sell
1,474,165
-106,210
-7% -$675K 0.01% 648
2024
Q1 		$13.4M Buy
1,580,375
+444,444
+39% +$3.88M 0.03% 545
2023
Q4 		$7.5M Buy
1,135,931
+93,400
+9% +$460K 0.02% 639
2023
Q3 		$3.22M Hold
1,042,531
– – 0.01% 709
2023
Q2 		$2.81M Hold
1,042,531
– – 0.01% 723
2023
Q1 		$3.1M Hold
1,042,531
– – 0.01% 747
2022
Q4 		$2.63M Hold
1,042,531
– – 0.01% 797
2022
Q3 		$1.9M Hold
1,042,531
– – ﹤0.01% 857
2022
Q2 		$3.28M Sell
1,042,531
-500,000
-32% -$2.79M 0.01% 846
2022
Q1 		$9.53M Hold
1,542,531
– – 0.02% 710
2021
Q4 		$21.9M Hold
1,542,531
– – 0.04% 431
2021
Q3 		$12.3M Buy
1,542,531
+192,531
+14% +$3.06M 0.02% 633
2021
Q2 		$38.6M Hold
1,350,000
– – 0.08% 272
2021
Q1 		$39.2M Buy
+1,350,000
New +$31.4M 0.08% 262

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Adage Capital Partners's EPIX Position: Q4 2024 in Review

Adage Capital Partners sold out of ESSA Pharma (EPIX) in Q4 2024, closing a stake of 1,474,165 shares — an estimated $8.93M sold.

Adage Capital Partners first reported a position in EPIX in Q1 2021 and held it in 15 quarters. The position peaked at $39.2M in Q1 2021. 46 funds tracked by Wall St. Rank hold EPIX as of Q4 2024.

  • Adage Capital Partners reported no remaining ESSA Pharma position as of Q4 2024 after selling out during the quarter.
  • Adage Capital Partners sold 1,474,165 ESSA Pharma shares in Q4 2024, an estimated $8.93M.
  • Adage Capital Partners first reported a position in ESSA Pharma in Q1 2021 and held it in 15 quarters.
  • Adage Capital Partners's ESSA Pharma position peaked at $39.2M in Q1 2021.
  • 46 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2024.

Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.